Last reviewed · How we verify
Investigational Medicinal Product — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Investigational Medicinal Product (Investigational Medicinal Product) — Imperial College London.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Investigational Medicinal Product TARGET | Investigational Medicinal Product | Imperial College London | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Investigational Medicinal Product CI watch — RSS
- Investigational Medicinal Product CI watch — Atom
- Investigational Medicinal Product CI watch — JSON
- Investigational Medicinal Product alone — RSS
Cite this brief
Drug Landscape (2026). Investigational Medicinal Product — Competitive Intelligence Brief. https://druglandscape.com/ci/investigational-medicinal-product. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab